Insider Brief
- Kvantify is partnering with Aarhus University and Aalborg University on the ODAQS project, funded with DKK 17.4 million by Innovation Fund Denmark, to advance quantum computing applications in drug discovery.
- The project aims to develop quantum software that reduces technical barriers and enables researchers and companies to focus on scientific problems rather than hardware limitations.
- ODAQS runs from 2026 to 2029 and will combine research in algorithms, software optimization, and automated quantum program generation, with a focus on quantum chemistry.
PRESS RELEASE — Kvantify is partnering with Aarhus University and Aalborg University in a new project designed to bring quantum computing closer to real-world application in drug discovery.
The project, Optimal Design Automation towards a Performant Quantum Software Stack (ODAQS), has received DKK 17.4 million in funding from the Innovation Fund Denmark (Grand Solutions program). The goal is to develop advanced quantum software that removes many of today’s technical barriers, allowing researchers and companies to focus on scientific problems rather than hardware limitations.
Kvantify will help translate the project’s research results into practical, industry-ready technologies for quantum-based chemical and molecular calculations, which could reduce both time and costs in the early stages of drug development.
ODAQS runs from 2026 to 2029 and combines research in algorithms, software optimization and automated quantum program generation – with a particular focus on quantum chemistry. The collaboration aims to strengthen Denmark’s quantum ecosystem while accelerating the adoption of quantum computing in life sciences.
Read the full press release for more details about the project and partners: https://cs.au.dk/news-events/new-quantum-software-could-accelerate-future-medicines.
